View
215
Download
0
Category
Preview:
DESCRIPTION
WHY FOLLOW…WHEN YOU CAN LEAD! The Large Hadron Collider at CERN By: Professor Franz Muheim
Citation preview
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
WelcomeEdinburgh University Young
Scientific Researchers Association
To the
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Line up:
Introduction – Nicholas Groth Merrild
The Large Hadron Collider – Professor Franz Muheim
Principia Scientifica (Genetic Manipulation) – Elena Mogos vs David Peberdy
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
The Large Hadron Collider at CERN
By: Professor Franz Muheim
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Principia ScientificaGenetic Manipulation
Elena Mogos vs David Peberdy
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Gene manipulation
Elena Mogos
To what extent can it be used?
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
• It can be dangerous for the environment
Nature is very complex and a small change may have unknown consequences
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
• Can cause disappearance of the animals(or crops) with no economical interest • Organic farming can become
redundant
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
• Moral issues to be considered• Animals should be treated with
respect and dignity
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
• Religious people may be irritated by the idea
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
• Can even have catastrophic results
• Super-weeds, monsters, viruses, ill-making organisms
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Thank you!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
GENETIC MANIPULATION
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
VITAMIN A DEFICIENCY AND GOLDEN RICE
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
BACTERIA Insulin production
from genetically manipulated bacteria
Production of antibiotics
Also clotting factors, hGH, vaccines etc
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
NOT GERMLINE Designer babies, and
inheritable genetic manipulation... A problem for the future
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
BUT SOMATIC GENE THERAPY
X linked severe combined immunodeficiency – ‘bubble boy’. First successfully treated; 1990
Adrenoleukodystrophy (ALD) –Cognitive decline and adrenal failure. First successfully treated; 2010
Parkinsons disease – Cognitive decline. First successfully treated; 2010
Leber's congenital amaurosis – Blindness. First successfully treated; 2008
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Thank you!
EUYSRA
WHY FOLLOW…WHEN YOU CAN LEAD!
Contact:EUYSRA@gmail.com
Facebook Group: EUYSRA
Room at 34 NOW!
Recommended